Patricia K. Coyle - Concepedia

Author

Patricia K. Coyle

Also Known As

Coyle P, Coyle, Patricia K., P Coyle, P K Coyle, P. Coyle, P. K. COYLE, P. K. Coyle, P.K Coyle, P.K. Coyle, Patricia Coyle

297

Publications

10.4K

Citations

H-Index

150

Concepts

All Affiliations

Stony Brook University State University of New York Stony Brook University Hospital Stony Brook School Stony Brook Medicine

About

Patricia K. Coyle is an author at Stony Brook University specializing in medicine, neurology, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	54	4.8K
2	Health Sciences	10	10	1.6K
3	Public Health	4	4	228
4	Nursing	2	2	37
5	Natural Sciences	1	1	38

Patricia K. Coyle

106

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Ludwig Kappos, Amit Bar‐Or, Bruce Cree, The Lancet Neurological DisorderClinical NeurologyClinical TrialsSiponimod Versus PlaceboNeurological Monitoring	2018	896
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial Daniel D. Mikol, Frederik Barkhof, Peter Chang, The Lancet Neurology Autoimmune DiseaseDisease ProgressionNeurological DisorderMedicineSubcutaneous Interferon	2008	480
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor, Annals of Neurology	2007	423
Transthyretin sequesters amyloid beta protein and prevents amyloid formation. A. L. Schwarzman, Luisa Gregori, Michael P. Vitek, Proceedings of the National Academy of Sciences Alzheimer's DiseaseApolipoprotein EBiochemistryMedicineDementia	1994	412
Practice Guidelines for the Treatment of Lyme Disease Gary P. Wormser, Robert B. Nadelman, Raymond J. Dattwyler, Clinical Infectious Diseases Vector-borne PathogenAllergyZoonotic DiseaseSymptomatic TreatmentFish Immunology	2000	369
Fatigue therapy in multiple sclerosis Lauren Krupp, Patricia K. Coyle, C. Doscher, Neurology	1995	356
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. Jack H. Simon, David K.B. Li, Anthony Traboulsee, PubMed Neurological DisorderWhite MatterBrain LesionMagnetic Resonance ImagingNeurology	2006	287
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis Robert J. Fox, Christopher S. Coffey, Robin Conwit, New England Journal of Medicine	2018	270
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial Thomas Leist, Giancarlo Comi, Bruce Cree, The Lancet Neurology Oracle MsOral CladribineNeurological DisorderClinical NeurologyClinical Trials	2014	237
Establishing the Proteome of Normal Human Cerebrospinal Fluid Steven E. Schutzer, Tao Liu, Benjamin H. Natelson, PLoS ONE	2010	232

Page 1